Artivion makes medical devices and human tissues for heart and aorta surgery, including stent grafts and heart valves. AORT reports earnings on Thu, Nov 5, 2026.
Prices, price targets and earnings estimates for AORT are shown to AI Starter and AI Pro members. Ratings, flow and news are open to everyone.See plansSign in
No whale options trades in AORT in the last 90 days.
Total alerts
0
Bullish
0
0%
Bearish
0
0%
Date span
—
Loading…
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether AORT is in one of them and how their past AORT trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Artivion
Artivion is based in Kennesaw, Georgia, and makes medical devices and implantable human tissues for heart and aorta surgery. Its main product lines include aortic stent grafts, On-X mechanical heart valves, surgical sealants such as BioGlue, and processed human heart and vascular tissues. Its products are used mainly by cardiac and vascular surgeons and cardiologists to treat patients with aortic disease, such as heart valve disease and aneurysms. The company sells these products to hospitals and surgical teams around the world.
